References
- FournierTGuibourdencheJEvain-BrionDPlacenta201536Suppl 1S60S6525707740
- EzcurraDHumaidanPA review of luteinising hormone and human chorionic gonadotropin when used in assisted reproductive technologyReprod Biol Endocrinol2014129525280580
- AllahbadiaGRecombinant or urinary human chorionic gonadotropin in ovulation induction?J Obstet Gynaecol India201161662162323204676
- FonjallazPLoumayeERecombinant hCG (OVIDREL) and recombinant interferon-(beta)1a (REBIF). (No. 13 in a series of articles to promote a better understanding of the use of genetic engineering)J Biotechnol200187327928111411454
- EleryanMGAkhiyatSRengifo-PardoMEhrlichABiosimilars: potential implications for cliniciansClin Cosmet Investig Dermatol20169135142
- McCamishMWoollettGThe state of the art in the development of biosimilarsClin Pharmacol Ther201291340541722318617
- BerkowitzSAEngenJRMazzeoJRJonesGBAnalytical tools for characterizing biopharmaceuticals and the implications for biosimilarsNat Rev Drug Discov201211752754022743980
- KadamVBagdeSKarpeMKadamVA comprehensive overview on biosimilarsCurr Protein Pept Sci201617875676126916165
- SimoensSBiosimilar medicines and cost-effectivenessClinicoecon Outcomes Res20113293621935330
- SchiestlMStanglerTTorellaCCepeljnikTTollHGrauRAcceptable changes in quality attributes of glycosylated biopharmaceuticalsNat Biotechnol201129431031221478841
- ICHICH Harmonised Tripartite GuidelineComparability of Biotechnological/Biological Product Subject to Changes in their Manufacturing Process Q5E2005
- TsurutaLRLopes dos SantosMMoroAMBiosimilars advancements: moving on to the futureBiotechnol Prog20153151139114925708573
- ICHICH Harmonised Tripartite GuidelinePharmaceutical Development Q8 (R2)2009
- ICHICH Harmonised Tripartite GuidelineDevelopment and Manufacture of Drug Substances (Chemical Entities and Biotechnological/Biological Entities) Q112012
- VisserJFeuersteinIStanglerTSchmiedererTFritschCSchiestlMPhysicochemical and functional comparability between the proposed biosimilar rituximab GP2013 and originator rituximabBioDrugs201327549550723649935